IMMX
Immix Biopharma, Inc.Closed8.69−0.56 −6.05%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 8.70 +0.12%
Open
9.10
Prev close
9.25
Day range
8.669.29
52-week range
2.4815.10
Volume
1.48M0.90×
Mkt cap
720.43M
P/E ttm
—
Fwd P/E
-10.25
EPS ttm
-0.8800
Div yield
0.00%
Earnings
—
From 52w high
−42.45%
IMMX earnings and estimates
IMMX Next Report
Yahoo Finance · Nasdaq
Report date
Fri, Nov 6
After the close · estimated
EPS consensus
$−0.19
range −0.21 – −0.17
EPS growth vs year ago
+21.4%
year ago −0.24
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±35.3%
by Nov 20 · ATM straddle
Past 4 reactions
±2.9%
average move · beat 1 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 7, 2026 AMC | −0.18 | −0.18 | −2.44% | $0 | +4.2% | +12.9% |
| Mar '26 | May 7, 2026 AMC | −0.18 | −0.21 | +13.25% | $0 | +2.2% | +5.9% |
| Dec '25 | Mar 25, 2026 AMC | −0.28 | −0.16 | −75.00% | $0 | −2.1% | −3.3% |
| Sep '25 | Nov 7, 2025 AMC | −0.24 | −0.19 | −26.32% | $0 | +2.9% | +33.7% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.19 | −0.21−0.17 | +21.4% | $0 | 0.0% | −0.19 +1.6% | −0.17 −9.8% | 0 / 2 |
| Next quarter Dec 2026 | −0.19 | −0.21−0.17 | +31.6% | $0 | 0.0% | −0.20 +4.3% | −0.19 −0.8% | 1 / 0 |
| Current year Dec 2026 | −0.71 | −0.77−0.51 | +19.8% | $0 | 0.0% | −0.74 +4.0% | −0.69 −3.2% | 2 / 1 |
| Next year Dec 2027 | −0.85 | −1.45−0.20 | −18.7% | $27.86M | 0.0% | −0.90 +6.2% | −0.74 −14.3% | 2 / 2 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.19 | −0.20−0.17 | 3 | 0 / 0 |
| Dec 2026 | −0.19 | — | 2 | 0 / 0 |
| Mar 2027 | −0.23 | — | 1 | 0 / 0 |
| Jun 2027 | −0.27 | — | 1 | 0 / 0 |
| Sep 2027 | −0.01 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.74 | −0.77−0.72 | 4 | 1 / 0 |
| Dec 2027 | −0.59 | −1.28−0.20 | 3 | 0 / 1 |
| Dec 2028 | −0.27 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.